Anti-flagellin (CBir1) phenotypic and genetic Crohn's disease associations

Inflammatory Bowel Diseases

Volumn 13, Issue 5, 2007, Pages 524-530

  Papadakis, Konstantinos A ^a,e   Yang, Huiying ^a   Ippoliti, Andrew ^a   Mei, Ling ^a   Elson, Charles O ^b   Hershberg, Robert M ^c   Vasiliauskas, Eric A ^a   Fleshner, Phillip R ^a   Abreu, Maria T ^d   Taylor, Kent ^a   Landers, Carol J ^a   Rotter, Jerome I ^a   Targan, Stephan R ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b University of Alabama at Birmingham   (United States)

^c University of Alabama ^*  (United States)

^d MOUNT SINAI MEDICAL CENTER   (United States)

^e Mount Sinai Medical Center ^*  (United States)

Author keywords

Clinical phenotypes; Colitis; Crohn's disease; Flagellin

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15; FLAGELLIN; FLAGELLIN ANTIBODY; GENOMIC DNA; OUTER MEMBRANE PROTEIN C; PROTEIN ANTIBODY; UNCLASSIFIED DRUG;

ANTIGEN ANTIBODY REACTION; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CROHN DISEASE; DEMOGRAPHY; DISEASE ASSOCIATION; GENE FREQUENCY; GENETIC DISORDER; HUMAN; MAJOR CLINICAL STUDY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NONHUMAN; PHENOTYPE; POPULATION RESEARCH; PRIORITY JOURNAL; PROTEIN VARIANT; SMALL INTESTINE RESECTION; ULCERATIVE COLITIS;

ANTIBODY FORMATION; ANTIGENS, BACTERIAL; ANTIGENS, FUNGAL; CROHN DISEASE; FLAGELLIN; HUMANS; INTESTINES; NOD2 SIGNALING ADAPTOR PROTEIN; PHENOTYPE; PORINS; SACCHAROMYCES CEREVISIAE; SUPERANTIGENS;

EID: 33847664069     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.20106     Document Type: Article

References (25)

1. Podolsky DK. Inflammatory bowel disease [see Comment]. N Engl J Med. 2002;347:417-429.
2. Targan SR, Landers CJ, Yang H, et al. Antibodies to CBir1 flagellin define a unique response that is associated independently with complicated Crohn's disease. Gastroenterology. 2005;128:2020-2028.
3. Mow WS, Vasiliauskas EA, Lin YC, et al. Association of antibody responses to microbial antigens and complications of small bowel Crohn's disease [see Comment]. Gastroenterology. 2004;126:414-424.
4. Arnott ID, Landers CJ, Nimmo EJ, et al. Sero-reactivity to microbial components in Crohn's disease is associated with disease severity and progression, but not NOD2/CARD15 genotype. Am J Gastroenterol. 2004;99:2376-2384.
5. Dubinsky MC, Lin YC, Dutridge D, et al., Western Regional Pediatric IBDRA. Serum immune responses predict rapid disease progression among children with Crohn's disease: immune responses predict disease progression. Am J Gastroenterol. 2006;101:360-367.
6. Abreu MT, Taylor KD, Lin YC, et al. Mutations in NOD2 are associated with fibrostenosing disease in patients with Crohn's disease. Gastroenterology. 2002;123:679-688.
7. Ahmad T, Armuzzi A, Bunce M, et al. The molecular classification of the clinical manifestations of Crohn's disease [see Comment]. Gastroenterology. 2002;122:854-866 [erratum, Gastroenterology, 2003;125: 281].
8. Cuthbert AP, Fisher SA, Mirza MM, et al. The contribution of NOD2 gene mutations to the risk and site of disease in inflammatory bowel disease [see comment]. Gastroenterology. 2002;122:867-874.
9. Hampe J, Grebe J, Nikolaus S, et al. Association of NOD2 (CARD 15) genotype with clinical course of Crohn's disease: a cohort study. Lancet. 2002;359:1661-1665.
10. Lesage S, Zouali H, Cezard JP, et al. CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease. Am J Hum Genet. 2002;70:845-857.
11. Mei L, Targan SR, Landers CJ, et al. Familial expression of anti-Escherichia coli outer membrane porin C in relatives of patients with Crohn's disease. Gastroenterology. 2006;130:1078-1085.
12. Lodes MJ, Cong Y, Elson CO, et al. Bacterial flagellin is a dominant antigen in Crohn disease. J Clin Invest. 2004;113:1296-1306.
13. Vasiliauskas EA, Plevy SE, Landers CJ, et al. Perinuclear antineutrophil cytoplasmic antibodies in patients with Crohn's disease define a clinical subgroup [see Comment]. Gastroenterology. 1996;110:1810-1819.
14. Vasiliauskas EA, Kam LY, Karp LC, Gaiennie J, Yang H, Targan SR. Marker antibody expression stratifies Crohn's disease into immunologically homogeneous subgroups with distinct clinical characteristics. Gut. 2000;47:487-496.
15. Hampe J, Cuthbert A, Croucher PJ, et al. Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations [see Comment]. Lancet. 2001;357:1925-1928 [erratum, Lancet, 2002;360:806].
16. Hugot JP, Chamaillard M, Zouali H, et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease [see Comment]. Nature. 2001;411:599-603.
17. Ogura Y, Bonen DK, Inohara N, et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease [see Comment]. Nature. 2001;411:603-606.
18. Kutyavin IV, Afonina IA, Mills A, et al. 3′-Minor groove binder-DNA probes increase sequence specificity at PCR extension temperatures. Nucleic Acids Res. 2000;28:655-661.
19. Landers CJ, Cohavy O, Misra R, et al. Selected loss of tolerance evidenced by Crohn's disease-associated immune responses to auto- and microbial antigens. Gastroenterology. 2002;123:689-699.
20. Brant SR, Picco MF, Achkar JP, et al. Defining complex contributions of NOD2/CARD15 gene mutations, age at onset, and tobacco use on Crohn's disease phenotypes. Inflamm Bowel Dis. 2003;9:281-289.
21. Smith BR, Arnott ID, Drummond HE, Nimmo ER, Satsangi J. Disease location, anti-Saccharomyces cerevisiae antibody, and NOD2/CARD15 genotype influence the progression of disease behavior in Crohn's disease. Inflamm Bowel Dis. 2004;10:521-528.
22. Devlin S, Ippoliti A, Mei L, et al. NOD2/CARD15 variants are significantly associated with sero-reactivity to microbial antigens in patients with Crohn's disease and their unaffected relatives. Gastroenterology. 2007 (in press).
23. Ramos HC, Rumbo M, Sirard JC. Bacterial flagelline: mediators of pathogenicity and host immune responses in mucosa. Trends Microbiol. 2004;12:509-517.
24. Hayashi F, Smith KD, Ozinsky A, et al. The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5. Nature. 2001;410: 1099-1103.
25. Means TK, Hayashi F, Smith KD, Aderem A, Luster AD. The Toll-like receptor 5 stimulus bacterial flagellin induces maturation and chemokine production in human dendritic cells. J Immunol. 2003;170:5165-5175.